Lawyers who won a ruling blocking the Florida Medicaid program from restricting coverage of a popular prescription drug say the state’s recent decision to drop its appeal sets an important precedent for what Florida and other states can and cannot do on drug coverage rules.
A key dispute in the case was over whether Congress intended Medicaid programs to cover all prescription drug uses listed in three congressionally approved drug compendia whether they’re FDA-approved or not. Or, did the lawmakers designate only those drugs listed in the compendia as being supported by research as effective? The issue remains disputed by both sides.
